Psilocybin during the postpartum period induces long-lasting adverse effects in both mothers and offspring
Nature Communications September 30, 2025 Cassandra J. Hatzipantelis, Min Liu, A. H. G. Love et al. 2 citations
Abstract Psilocybin increases social connectedness and has strong clinical transdiagnostic efficacy for mental illness, making it a candidate treatment to reduce maternal disconnect, anxiety, and blunted affect seen in peripartum mood disorders. However, the efficacy and safety of psilocybin in peripartum mood disorders has not been investigated. We used a social stress model to examine the...